Medical testing services provider Quest Diagnostics, Inc. (DGX: Quote) announced Thursday that Senior Vice President and Chief Financial Officer Robert Hagemann plans to leave the company on May 31, 2013. He may leave earlier if a successor is named and the transition is complete before the end of May.
"We are grateful to Bob for his service to Quest Diagnostics and the leadership he has demonstrated since joining the company in 1992. Quest Diagnostics has benefited enormously from Bob's financial and business expertise over his long tenure with the company," President and CEO Steve Rusckowski said in a statement.
The Madison, New Jersey-based company said it is launching a search for a new CFO that will consider both internal and external candidates, with Hagemann assisting in identifying his successor.
Hagemann, who had a 21 career with the company, has been serving as CFO for the past fifteen years since August 1998. He joined Corning Life Sciences, Inc. in 1992, and came to Quest Diagnostics after it was spun-off from corning in 1996.
After holding various senior financial positions in Corning Life Sciences from 1992, Hagemann was named vice president and corporate controller of the company in 1996.
Prior to joining Corning Life Sciences in 1992, Hagemann was employed by Prime Hospitality, Inc. and Crompton & Knowles, Inc. in senior financial positions. He was also previously associated with Ernst & Young.
"At this point, after 21 years with the company and almost 15 years as the CFO, we agreed now is a good time for a change. I thank everyone at Quest for the tremendous support I have received over the years," Hagemann noted.
DGX closed Wednesday's regular trading session at $55.99, down $0.28 on a volume of 0.90 million shares.
| || |
| To receive FREE breaking news email alerts for Quest Diagnostics and others in your portfolio|
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org